Therapeutic antibodies against SARS-CoV-2 based on camelid nanobodies

A panel of high affinity nanobodies (Nb) binding to diverse SARS-CoV-2 RBD epitopes of spike protein, and a set of nanobody-derived neutralizing…

Bacterias recombinantes para producir plásticos a partir de residuos de biomasa vegetal

Cepa de Pseudomonas putida diseñada mediante biología sintética capaz de producir ácido 5-carboximetilpiridín-2-carboxílico (2,5-CPDCA) a partir de…

Recombinant bacteria for producing plastics from plant biomass waste

A Pseudomonas putida strain engineered through synthetic biology capable of producing 5-carboxymethylpyridine-2-carboxylic acid (2,5-CPDCA) from…

Nuevas vacunas basadas en replicones de RNA contra virus como SARS-CoV-2 y MERS-CoV

Se han desarrollado dos prototipos diferentes de vacunas basadas en replicones de ARN del SARS-CoV-2 y MERS-CoV, encapsulados en partículas similares…

New vaccines based on RNA replicons against viruses such as MERS-CoV and SARS-CoV-2

Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs…

Vacuna para la prevención de la anaplasmosis

Vacuna basada en un antígeno quimérico recombinante que puede ser usado para la prevención o el tratamiento de infecciones causadas por Anaplasma…

Vaccine for the prevention of anaplasmosis

Recombinant chimeric antigen used for the prevention or treatment of infections caused by Anaplasma phagocytophilum.